Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that i…
Biotechnology
US, Encinitas [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Ventyx Biosciences, Inc. has no acquisition track records yet.
M&A Deals · History
Ventyx Biosciences, Inc. has no acquisition track records yet.